Leprosy is a spectral disease which provides a unique clinical model for investigating resistance and tolerance to an infectious pathogen. It is within the tissue lesions that the battle between the immune and the pathogen is joined. Therefore, our approach has been aimed at studying immune cells in lesions which are likely to be critical to the pathogenesis of leprosy. Hence, this study is designed to investigate the immunoregulatory processes that occur in lesions of leprosy. Our demonstrated expertise with monoclonal antibodies and immunoperoxidase staining will be used to characterize cells in situ in lesions by studying their cell surface phenotype and microanatomical location. These studies will be advanced by the detection of mRNA coding for proteins critical to immunoregulation by in situ hybridization. We have developed new methods of studying the immune function of cells in lesions by extracting and purifying cells from skin biopsy specimens of leprosy patients. Limiting dilution analysis will be performed on lymphocytes to provide information as to the relative frequency of M. leprae reactive cells from lesions versus blood and the delineation of immunodominant M. leprae antigens. In addition, cloning of T-helper and T-suppressor lymphocytes from tissue-derived cells will provide reagents for determination of 1) the range of antigens and epitopes recognized by the immunologic repertoire of patients; 2) the functional response elicited by a given epitope; and 3) the mechanism by which T- suppressor cells contribute to immunologic tolerance. The cumulative effect of the attainment of these goals will be the understanding of the immunoregulatory processes that contribute to resistance and tolerance to M. leprae and the identification of the precise epitopes that contribute to protective immunity. This will lead to more exacting immunodiagnostic reagents and more logical intervention strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Unknown (R22)
Project #
2R22AI022553-04A1
Application #
3444837
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1986-04-01
Project End
1993-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Chung, Andrew W; Sieling, Peter A; Schenk, Mirjam et al. (2013) Galectin-3 regulates the innate immune response of human monocytes. J Infect Dis 207:947-56
Schenk, Mirjam; Krutzik, Stephan R; Sieling, Peter A et al. (2012) NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med 18:555-63
Torrelles, Jordi B; Sieling, Peter A; Zhang, Nannan et al. (2012) Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. Glycobiology 22:1118-27
Liu, Philip T; Wheelwright, Matthew; Teles, Rosane et al. (2012) MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 18:267-73
Fabri, Mario; Realegeno, Susan E; Jo, Eun-Kyeong et al. (2011) Role of autophagy in the host response to microbial infection and potential for therapy. Curr Opin Immunol 23:65-70
Fabri, Mario; Stenger, Steffen; Shin, Dong-Min et al. (2011) Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 3:104ra102
Modlin, Robert L (2010) The innate immune response in leprosy. Curr Opin Immunol 22:48-54
Lee, Delphine J; Li, Huiying; Ochoa, Maria T et al. (2010) Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis 201:558-69
Edfeldt, Kristina; Liu, Philip T; Chun, Rene et al. (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A 107:22593-8
Teles, Rosane M B; Krutzik, Stephan R; Ochoa, Maria T et al. (2010) Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy. Infect Immun 78:4634-43

Showing the most recent 10 out of 111 publications